Pharmacogenomic Analysis Reveals <i>CCNA2</i> as a Predictive Biomarker of Sensitivity to Polo-Like Kinase I Inhibitor in Gastric Cancer

Por Yunji Lee, Chae Eun Lee, Sejin Oh, Hakhyun Kim, Jooyoung Lee, Sang Bum Kim, Hyun Seok Kim
Publicado em 2020-05-01